Sanofi Gruop

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. In 2016, Sanofi’s net sales amounted to €33,821 million. Sanofi has a strong commitment to China. In 1982, Sanofi became one of the first foreign pharmaceutical companies to open offices in China. Sanofi China has a diversified business that ranges from pharmaceuticals, vaccines to consumer healthcare. Today, Sanofi has more than 9,000 employees in China and is one of the fastest-growing healthcare companies in the country. Sanofi’s China headquarters are in Shanghai, supported by 11 branches in Beijing, Tianjin, Shenyang, Shanghai, Hangzhou, Nanjing, Wuhan, Chengdu, Guangzhou, Jinan and Urumqi. Sanofi currently has five manufacturing facilities in Beijing (pharmaceutical), Hangzhou (one pharmaceutical, one consumer healthcare), Shenzhen (vaccine) and Tangshan (consumer healthcare).